West Pharmaceutical Services Inc
Open
SectorHealthcare
342.39 2.95
Overview
Share price change
24h
Min
332.48
Max
345.79
Income | 6.7M 139M |
|---|---|
Sales | 40M 845M |
P/E Sector Avg | 44.079 49.712 |
EPS | 2.13 |
Dividend yield | 0.26 |
Profit margin | 16.428 |
Employees | 10,800 |
EBITDA | 9M 219M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +10.88% upside |
Dividend yield Sector Avg | 0.26% 2.36% |
|---|---|
Next Earnings | 23 Jul 2026 |
Next Dividend date | 5 Aug 2026 |
Next Ex Dividend date | 29 Jul 2026 |
Market Cap | 3.3B 23B |
|---|---|
Previous open | 339.44 |
Previous close | 342.39 |
News Sentiment
By Acuity
50%
50%
143 / 342 Healthcare
West Pharmaceutical Services Inc Chart
Past performance is not a reliable indicator of future results.
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.